Online ⁠pharmacy platform

在线药店平台

SaveRxCanada

保存Rx加拿大

.to said on Wednesday it has begun offering

。周三表示已开始提供

Novo Nordisk

诺和诺德

's blockbuster

的重磅炸弹

diabetes drug

糖尿病药物

,

，

Ozempic

欧泽匹克

, sourced from India to

，源自印度

U.S. patients

美国患者

, as demand for cheaper options grows.

，随着对更便宜选项的需求增长。

The Canada-based ‌company said ‌the

总部位于加拿大的公司表示

India-sourced Ozempic

印度来源的Ozempic

injections are priced from about $280 per pen, compared with U.S. retail pharmacy prices ‌that typically range between $900 and $1,100 per pen depending on dose and location.

每支注射剂的价格约为280美元，而美国零售药房的价格通常根据剂量和地点不同，每支在900至1100美元之间。

It was not clear how the online pharmacy was obtaining the weight-loss treatment. The company did not respond to an emailed request for comment about its sourcing. When contacted by phone on Thursday using the toll-free number listed on SaveRxCanada.to, a person said the company ‌had no ‍comment.

目前还不清楚这家网上药店是如何获得这种减肥治疗药物的。该公司没有回应通过电子邮件发送的关于其采购来源的评论请求。当记者周四使用SaveRxCanada.to上列出的免费电话联系到该公司时，一名工作人员表示公司对此无可奉告。

'We have no customer or partner relationship with this company/platform, ‍and Ozempic from India has not been provided to ‌them,' a Novo Nordisk spokesperson told Reuters in an email on Thursday when asked about SaveRxCanada.to.

“我们与这家公司/平台没有任何客户或合作伙伴关系，而且印度的Ozempic并未提供给他们，”诺和诺德发言人在周四通过电子邮件向路透社表示，当时被问及SaveRxCanada.to的情况。

A spokesperson for the U.S. Department of Health and Human Services declined to comment on the company's distribution claims, pointing consumers to the FDA's BeSafeRx resource on how to safely buy prescription medicines online.

美国卫生与公众服务部的一位发言人拒绝就该公司的分销声明发表评论，而是引导消费者参考 FDA 的 BeSafeRx 资源，了解如何安全地在线购买处方药。

Live Events

现场活动

The platform is offering several pre-filled ‍pens including 0.25 mg, 0.5 mg and 1 mg doses, and said products clearly disclose the manufacturer and country ‍of origin.

该平台提供了几种预填充笔，包括 0.25 毫克、0.5 毫克和 1 毫克剂量，并且产品清楚标明了制造商和原产国。

All orders ⁠require a valid ⁠prescription and include free shipping, it added.

所有订单都需要有效的处方，并包括免费送货，它补充道。

'Many patients are actively comparing prescription costs as U.S. prices continue to rise,' the company said in a statement.

“随着美国药品价格持续上涨，许多患者正在积极比较处方药费用，”该公司在一份声明中表示。

The platform, which describes itself as an international prescription referral service, said it has operated for 24 years connecting patients with licensed pharmacies outside the United States.

该平台自称是一家国际处方转诊服务机构，表示其运营了24年，将患者与美国以外的有执照的药店联系起来。

International pharmacy services have drawn interest from U.S. consumers facing rising out-of-pocket drug expenses.

国际药房服务引起了面临自付药物费用上涨的美国消费者的兴趣。

Add

添加

as a Reliable and Trusted News Source

作为可靠和值得信赖的新闻来源

Add Now!

立即添加！

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)